1. Home
  2. ABUS vs EVER Comparison

ABUS vs EVER Comparison

Compare ABUS & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABUS
  • EVER
  • Stock Information
  • Founded
  • ABUS N/A
  • EVER 2008
  • Country
  • ABUS United States
  • EVER United States
  • Employees
  • ABUS N/A
  • EVER N/A
  • Industry
  • ABUS Biotechnology: Pharmaceutical Preparations
  • EVER Computer Software: Programming Data Processing
  • Sector
  • ABUS Health Care
  • EVER Technology
  • Exchange
  • ABUS Nasdaq
  • EVER Nasdaq
  • Market Cap
  • ABUS 725.9M
  • EVER 631.9M
  • IPO Year
  • ABUS N/A
  • EVER 2018
  • Fundamental
  • Price
  • ABUS $3.46
  • EVER $19.36
  • Analyst Decision
  • ABUS Strong Buy
  • EVER Strong Buy
  • Analyst Count
  • ABUS 4
  • EVER 6
  • Target Price
  • ABUS $5.50
  • EVER $28.50
  • AVG Volume (30 Days)
  • ABUS 837.4K
  • EVER 655.1K
  • Earning Date
  • ABUS 11-06-2024
  • EVER 11-04-2024
  • Dividend Yield
  • ABUS N/A
  • EVER N/A
  • EPS Growth
  • ABUS N/A
  • EVER N/A
  • EPS
  • ABUS N/A
  • EVER 0.38
  • Revenue
  • ABUS $6,742,000.00
  • EVER $408,440,000.00
  • Revenue This Year
  • ABUS N/A
  • EVER $69.91
  • Revenue Next Year
  • ABUS N/A
  • EVER $18.99
  • P/E Ratio
  • ABUS N/A
  • EVER $51.15
  • Revenue Growth
  • ABUS N/A
  • EVER 27.43
  • 52 Week Low
  • ABUS $1.79
  • EVER $8.44
  • 52 Week High
  • ABUS $4.72
  • EVER $28.09
  • Technical
  • Relative Strength Index (RSI)
  • ABUS 30.63
  • EVER 51.89
  • Support Level
  • ABUS $3.42
  • EVER $17.37
  • Resistance Level
  • ABUS $3.81
  • EVER $19.64
  • Average True Range (ATR)
  • ABUS 0.16
  • EVER 1.22
  • MACD
  • ABUS -0.04
  • EVER 0.13
  • Stochastic Oscillator
  • ABUS 7.41
  • EVER 54.63

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

Share on Social Networks: